Skip to main content

Table 2 Summary of EVs administration for NDDs

From: Peripheral extracellular vesicles in neurodegeneration: pathogenic influencers and therapeutic vehicles

Original cells or tissues

Cargo

Function

Disease

Reference

Curcumin

Inhibit hyperphosphorylation of tau

AD

[152]

Blood plasma

Quercetin

Inhibit phosphorylation of tau

AD

[151]

AD-MSCs, BM-MSCs

NEP

Degrade Aβ

AD

[94, 160]

BM-MSCs

SHP2

Alleviate mitochondrial damage-mediated apoptosis

AD

[153]

BM-MSCs

CB2 receptor agonist (AM1241)

Facilitate Aβ phagocytosis and promote neurogenesis

AD

[150]

DCs

BACE1 siRNAs

Knockdown of BACE1

AD

[137]

BM-MSCs, HEK-293T cells

miR-29

Downregulate BACE1

AD

[156]

AD-MSCs

miR-22

Inhibit apoptosis and ameliorate neuroinflammation

AD

[157]

Fresh serum

Dopamine

Increase dopamine distribution in brain

PD

[154]

Mϕ, BM-MSCs

Catalase

Antioxidant effect

PD, AD

[138, 161]

GDNF

Ameliorate neuroinflammation

PD

[162]

Human umbilical cord-derived MSCs

m6A demethylase FTO-targeted siRNAs

Alleviate dopaminergic neuronal death

PD

[158]

Trophoblast- derived MSCs

miR-100a-5p

Antioxidant effect

PD

[163]

hBM-EPCs

Angiogenic factors

Ameliorate impaired brain endothelial cells

ALS

[67]

AD-MSCs

let-7b, miR-9, miR-124

Promote neurogenesis

-

[125]

  1. Abbreviations: AD: Alzheimer’s disease, Aβ: amyloid-β peptides, PD: Parkinson’s disease, ALS: Amyotrophic lateral sclerosis, DCs: dendritic cells, Mϕ: macrophages, MSCs: mesenchymal stem cells, BM-MSCs: bone marrow-derived MSCs, AD-MSCs: adipose tissue-derived MSCs, NEP: Neprilysin, SHP2: tyrosine phosphatase-2, GDNF: glial cell-line derived neurotropic factor, hBM-EPCs: human bone marrow endothelial progenitor cells